Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H7063

Blue Cross and Blue Shield of Kansas

10,220 members

3

-0.5 vs 2026Below the 4 star line

Ask about H7063

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

3 · 2.0 pt to 4★

Medication Adherence for Hypertension (RAS antagonists)

4 · 2.0 pt to 5★

Medication Adherence for Cholesterol (Statins)

4 · 2.0 pt to 5★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan30.35
C17 Plan All-Cause Readmissions3x56%
C28 Members Choosing to Leave the Plan416%
C19 Transitions of Care241%
C16 Improving Bladder Control345%
C06 Monitoring Physical Activity246%
C15 Reducing the Risk of Falling151%
C13 Kidney Health Evaluation for Patients with Diabetes255%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions259%
C14 Controlling High Blood Pressure3x165%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.